| FDA approves Merck's kidney disease treatment - CSL Recruitment |
|
|
CSL Recruitment The approval from the FDA came after the publication of results from the Study of Heart and Renal Protection (Sharp). Dr Mendelsohn added: "The results of Sharp as described in the new label for Vytorin can help the medical community understand the ... New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes |